Rubicon Founders LLC

NASHVILLE, TN · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$147.1M2026 Q3
Positions3
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Rubicon Founders LLC reported 3 positions worth $147.1M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: PRVA (86.6%). Biggest move: reduce AGILON HEALTH INC ($11.3M).

3 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 PRVAPrivia Health$127.4M86.62%6,472,513——+28.3%
▸ 2 EVHEvolent Health$19.7M13.38%5,641,123——+40.4%
▸ 3Agilon HealthAgilon Health$0.000.00%0———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Rubicon Founders LLC hold as of Q3 2026?

Rubicon Founders LLC reported 3 positions worth $147.1M in its Q3 2026 13F filing. Largest positions: PRVA (86.6%), EVH (13.4%) and AGILON HEALTH INC (0.0%).

What did Rubicon Founders LLC buy in Q3 2026?

Added to: PRVA.

What did Rubicon Founders LLC sell in Q3 2026?

Reduced: AGILON HEALTH INC and EVH.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.